Accord Healthcare Recalls Cinacalcet Tablets Due to Nitrosamine Contamination
Accord Healthcare is recalling Cinacalcet 30mg tablets nationwide due to a nitrosamine impurity (N-nitroso-cinacalcet) exceeding acceptable daily intake limits. Patients should consult their healthcare provider to confirm if their medication is affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for a pharmaceutical contaminant (nitrosamine) exceeding acceptable daily intake limits. No reported illnesses or injuries are stated in the source, making the hazard theoretical rather than realized, which caps the score at 3 per the rubric.
Plain-English summary
Accord Healthcare, Inc. is recalling Cinacalcet 30mg tablets in a nationwide recall in the United States and Puerto Rico. The affected product is available in two package sizes: 30 tablets per bottle (NDC: 16729-440-10) and 90 tablets per bottle (NDC: 16729-440-15).
The recall is due to Current Good Manufacturing Practice (CGMP) deviations involving the detection of a nitrosamine impurity, N-nitroso-cinacalcet, present in the product at levels exceeding the acceptable daily intake (ADI) limit.
Patients taking Cinacalcet from the affected lot numbers should contact their healthcare provider or pharmacist to determine if their medication is included in the recall. Patients should not stop taking their medication without consulting their healthcare provider.
For more information about the affected lot numbers and expiry dates, patients and healthcare providers should contact Accord Healthcare, Inc. or check the FDA's official recall notice.
The recalled product
- Product
- CINACALCET (CINACALCET)
- Brand
- CINACALCET
- Manufacturer
- ACCORD HEALTHCARE, INC.
- Hazard
- nitrosamine
- manufacturing-defect
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CINACALCET
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- HighPrescription Cinacalcet Tablets Recalled for N-Nitroso Impurity
FDA (Drugs) · 2024-12-11
- HighFDA Recalls Cinacalcet 30mg Tablets for N-nitroso Impurity
FDA (Drugs) · 2024-12-11
Same category
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22